3 European Dividend Stocks To Enhance Your Portfolio

In This Article:

As European markets navigate a period of mixed economic signals, with the STOXX Europe 600 Index achieving its longest streak of weekly gains since 2012, investors are keenly observing how these dynamics might influence their portfolios. In such an environment, dividend stocks can offer a compelling opportunity for those looking to enhance portfolio stability and income potential amidst ongoing market uncertainties.

Top 10 Dividend Stocks In Europe

Name

Dividend Yield

Dividend Rating

Zurich Insurance Group (SWX:ZURN)

4.30%

★★★★★★

Julius Bär Gruppe (SWX:BAER)

4.29%

★★★★★★

Mapfre (BME:MAP)

5.91%

★★★★★★

Bredband2 i Skandinavien (OM:BRE2)

4.83%

★★★★★★

Rubis (ENXTPA:RUI)

7.47%

★★★★★★

Cembra Money Bank (SWX:CMBN)

4.40%

★★★★★★

Vaudoise Assurances Holding (SWX:VAHN)

4.35%

★★★★★★

Banque Cantonale Vaudoise (SWX:BCVN)

4.58%

★★★★★★

Credito Emiliano (BIT:CE)

6.02%

★★★★★☆

EFG International (SWX:EFGN)

4.29%

★★★★★☆

Click here to see the full list of 221 stocks from our Top European Dividend Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Føroya Banki

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Føroya Banki, with a market cap of DKK1.79 billion, offers personal and corporate banking services across the Faroe Islands, Denmark, and Greenland through its subsidiaries.

Operations: Føroya Banki generates revenue from several segments, including DKK293.77 million from personal banking, DKK129.13 million from corporate banking, and DKK29.41 million from non-life insurance in the Faroe Islands.

Dividend Yield: 4.5%

Føroya Banki's dividend outlook shows a mixed picture. The bank's dividends are currently well covered by earnings with a low payout ratio of 24.4%, and coverage is forecasted to remain sustainable in three years with a 72.7% payout ratio. However, the dividend has been unreliable and volatile over the past decade, despite recent growth in payments. With high bad loans at 5.2%, investors should consider potential risks alongside its favorable valuation, trading significantly below estimated fair value. Recent guidance revisions reflect improved profit expectations for 2024 due to lower impairments and strong investment returns, which may influence future dividend stability.

CPSE:FOBANK Dividend History as at Mar 2025
CPSE:FOBANK Dividend History as at Mar 2025

Orion Oyj

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Orion Oyj is a pharmaceutical company that develops, manufactures, and markets human and veterinary drugs as well as active pharmaceutical ingredients across Finland, Scandinavia, the rest of Europe, North America, and internationally with a market cap of €7.59 billion.